Skip to main content

CORRECTION article

Front. Med., 07 April 2021
Sec. Family Medicine and Primary Care
Volume 8 - 2021 | https://doi.org/10.3389/fmed.2021.677866
This article is part of the Research Topic Cardioprotection, Sex and Gender Differences View all 13 articles

Corrigendum: Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment

This article is a correction to:

  1. Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment

    1. Read original article
\nMichael LeutnerMichael Leutner1Caspar Matzhold,Caspar Matzhold2,3Alexander KautzkyAlexander Kautzky4Michaela Kaleta,Michaela Kaleta2,3Stefan Thurner,,,Stefan Thurner2,3,5,6Peter Klimek,Peter Klimek2,3Alexandra Kautzky-Willer, Alexandra Kautzky-Willer1,7*
  • 1Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
  • 2Section for Science of Complex Systems, Center for Medical Statistics, Informatics, and Intelligent Systems (CeMSIIS), Medical University of Vienna, Vienna, Austria
  • 3Complexity Science Hub Vienna, Vienna, Austria
  • 4Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
  • 5Santa Fe Institute, Santa Fe, NM, United States
  • 6Institute for Applied Systems Analysis (IIASA), Laxenburg, Austria
  • 7Gender Institute, Gars am Kamp, Austria

A Corrigendum on
Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment

by Leutner, M., Matzhold, C., Kautzky, A., Kaleta, M., Thurner, S., Klimek, P., et al. (2021). Front. Med. 8:608083. doi: 10.3389/fmed.2021.608083

In the original article, the authors' name and surname were swapped. The correct author list appears in this article. This has been corrected in all relevant sections. The citation was corrected to “Leutner M, Matzhold C, Kautzky A, Kaleta M, Thurner S, Klimek P and Kautzky-Willer A (2021) Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment. Front. Med. 8:608083. doi: 10.3389/fmed.2021.608083.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: statins, depression, dyslipidemia, dosage, precision medicine

Citation: Leutner M, Matzhold C, Kautzky A, Kaleta M, Thurner S, Klimek P and Kautzky-Willer A (2021) Corrigendum: Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment. Front. Med. 8:677866. doi: 10.3389/fmed.2021.677866

Received: 08 March 2021; Accepted: 09 March 2021;
Published: 07 April 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Leutner, Matzhold, Kautzky, Kaleta, Thurner, Klimek and Kautzky-Willer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Alexandra Kautzky-Willer, alexandra.kautzky-willer@meduniwien.ac.at

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.